There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cue Biopharma (CUE – Research Report) and Siemens Healthineers AG (SEMHF – Research Report) with bullish sentiments.
Cue Biopharma (CUE)
In a report released today, Michael King from H.C. Wainwright maintained a Buy rating on Cue Biopharma, with a price target of $20.00. The company’s shares closed last Wednesday at $10.60.
According to TipRanks.com, King is a 4-star analyst with an average return of
Cue Biopharma has an analyst consensus of Strong Buy, with a price target consensus of $27.60, a 177.7% upside from current levels. In a report released today, Berenberg Bank also maintained a Buy rating on the stock with a $30.00 price target.
Siemens Healthineers AG (SEMHF)
Berenberg Bank analyst Odysseas Manesiotis maintained a Buy rating on Siemens Healthineers AG yesterday and set a price target of EUR75.00. The company’s shares closed last Wednesday at $65.60.
According to TipRanks.com, Manesiotis is ranked #6720 out of 7757 analysts.
Currently, the analyst consensus on Siemens Healthineers AG is a Moderate Buy with an average price target of $78.47, implying a 19.6% upside from current levels. In a report issued on January 19, Jefferies also upgraded the stock to Buy with a EUR75.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on CUE:
- UBS Acquires Wealthfront for $1.4B, Expands US Presence
- Rosenblatt Securities Thinks Robinhood Markets’ Stock is Going to Recover
- Rosenblatt Securities Thinks Coinbase Global’s Stock is Going to Recover
- Rosenblatt Securities Keeps Their Buy Rating on SoFi Technologies (SOFI)
- These Stocks are the Biggest Pre-Market Movers on Thursday